Zegenex Named to Technical.ly's RealLIST Startups 2026 for Pittsburgh
Zegenex has been named to Technical.ly's RealLIST Startups 2026, the publication's yearly list of Pittsburgh's most promising early-stage companies.
Deep-dives into small-molecule wound care mechanisms, preclinical study findings, global healthcare access, and recognized media coverage.
Zegenex's work has been recognized by leading media outlets, research institutions and industry publications.
Access in-depth publications detailing zebrafish biosensors, ambient formulation stability, and clinical progress.
Zegenex has been named to Technical.ly's RealLIST Startups 2026, the publication's yearly list of Pittsburgh's most promising early-stage companies.
Researchers at the University of Pittsburgh are exploring how zebrafish could unlock new possibilities in wound healing and regenerative medicine.
A closer look at how zebrafish research is helping scientists understand complex healing processes — and what it could mean for future treatments.
The event highlighted groundbreaking research, innovation and the growing entrepreneurial ecosystem at Pitt.
We work with strategic biopharma partners, foundation grants, and visionary investors who share our conviction that healing should be universal — not constrained by infrastructure, refrigeration, or geography.